Covidien Initiates Aneurysm Device Recall
This article was originally published in The Gray Sheet
Executive Summary
The voluntary recall of Covidien’s Pipeline aneurysm embolization device and Alligator retrieval devices is expected to have a slight negative effect on earnings in the second half of the year, but the impact could increase if it takes longer than expected to replace the affected products, the firm suggested.